Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Journal of Clinical Investigation, 101(3), 515-520
When additional therapy is required, NICE recommends considering a GLP-1 receptor agonist (such as Rybelsus) if the patient has a BMI of 35 kg/m or higher (or 32.5 kg/m or higher for people of South Asian or related ethnicity) and specific psychological or medical problems associated with obesity, or if BMI is lower but insulin therapy would have significant occupational implications or weight loss would benefit other obesity-related comorbidities
Identification and functional analysis of glutathione S-transferases from Sitophilus zeamais in olfactory organ
Silva-Pinheiro P, Minczuk M
US$ 22.73
US$ 29.43
US$ 28.45
US$ 22.39
US$ 26.29
US$ 26.97
US$ 21.59
US$ 25.07
US$ 27.89
US$ 25.02
US$ 21.79
